Curaleaf has become the first company to register standardized THC- and CBD-dominant cannabis preparations in Spain under the country's new medicinal cannabis law, Royal Decree 903/2025. This approval by Spain's Agency of Medicines and Medical Devices allows Curaleaf to supply these pharmaceutical-grade cannabis products to hospital pharmacies for medical prescriptions. The milestone highlights Curaleaf's leadership and long-term investment in Spain, where it operates an EU-GMP certified facility. The preparations are expected to become available to patients as Spain's regulated system develops further.
CoreWeave is maintaining a strong buy rating with a 2027 price target of around $250 per share, driven by rapid backlog growth reaching $104 billion by Q2-end and a new financing facility (DDTL 5.5) that opens access to the enterprise market with hig...
An AI-managed stock portfolio by Grok turned $100,000 into $148,485 in less than nine months, outperforming the S&P 500's 14.10% return over the same period. The portfolio's strong gains were driven mainly by heavy investments in Micron Technology, b...
Anthropic, the AI company behind the Claude chatbot, reported a preliminary revenue of over $11.5 billion in Q2, a more than 14-fold increase from $787 million in the same quarter last year. This rapid growth highlights Anthropic's rising position in...
Memory stocks like SanDisk and Micron saw a sharp rebound after SanDisk forecasted mid-to-high-teens revenue growth and stable gross margins around 80% through 2028-2030. This eased earlier bearish sentiment driven by social media and concerns over p...
Nvidia has begun full production of its Spectrum-X Ethernet Photonics platform, the first co-packaged optics Ethernet switch designed for 200G-per-lane volume shipping. This innovation integrates optics directly onto the switch chip, drastically redu...
